Rising incidence of breast cancer: relationship to stage and receptor status

J Natl Cancer Inst. 1990 Apr 18;82(8):693-6. doi: 10.1093/jnci/82.8.693.

Abstract

We used the population-based tumor registry of Kaiser Permanente in the United States (Portland, OR) to analyze breast cancer incidence from 1960 to 1985. Overall, incidence rose 45% during this period. The largest increases occurred in women 60 years of age or older (74%) and in those 45-59 (36%). The rate in women aged 20-44 has remained essentially unchanged. Localized and regional disease showed similar increases. Review of medical records revealed that only a small portion of this increase was likely to result from increased screening activities. From the increased availability of receptor assays in a large proportion of cases since the mid-1970s, we observed that incidence of estrogen receptor-negative cancers rose 22%-27% between the mid-1970s and the mid-1980s. In contrast, incidence of estrogen receptor-positive tumors increased an average of 131% in the same period, perhaps implicating hormonal factors in the rising incidence of breast cancer.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / analysis
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / mortality
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasm Staging
  • Receptors, Estrogen / analysis*
  • Registries
  • Survival Rate
  • Time Factors
  • United States / epidemiology

Substances

  • Receptors, Estrogen